You can buy or sell IRWD and other stocks, options, ETFs, and crypto commission-free!
Ironwood Pharmaceuticals, Inc. Class A Common Stock, also called Ironwood Pharmaceuticals, is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Read More Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected Apr 30, Pre-Market